You just read:

AcelRx Pharmaceuticals Submits New Drug Application for ARX-04 for the Treatment of Moderate-To-Severe Acute Pain

News provided by

AcelRx Pharmaceuticals, Inc.

Dec 13, 2016, 07:00 ET